SecBot SecBot
8-K ·Filed Aug 5, 2026

COR

Cencora, Inc.
NEUTRAL
Impact 3/10
Horizonimmediate Processed3mo ago SEC0001104659-26-090691
8-K material event: Items 1.01
Actionable Insight • Neutral

These amendments streamline Cencora's capital structure by reducing a secured securitization line and increasing unsecured accordion flexibility. Monitor for any future drawdowns under the new $7B credit facility or utilization of the expanded accordion; the changes are neutral for common equity holders as no earnings data is affected.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$317.22
T+0 close · Aug 5, 2026 · via day close
Latest settled
+3.48%
T+60 · $328.25
Vs SPY
+3.28%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 5 $317.22entry
  2. T+1 · 3mo ago +2.46%α +2.62% · $325.01
  3. T+5 · 3mo ago −0.96%α −1.31% · $314.17
  4. T+20 · 3mo ago +6.03%α +6.64% · $336.36
  5. T+60 · 19d ago +3.48%α +3.28% · $328.25
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Cencora entered into the 23rd amendment to its receivables purchase facility, reducing the purchase limit from $1.5B to $1.0B while increasing the accordion capacity from $500M to $1.0B, and added BBVA as a new purchaser. Separately, the company amended and restated its $7.0B unsecured credit agreement with a new July 31, 2031 maturity. These actions represent routine capital structure management and do not reflect any material change in the company's financial condition.

Key Facts

  • Receivables purchase facility limit decreased from $1.5B to $1.0B; accordion purchase limit increased from $500M to $1.0B
  • BBVA joined as a new purchaser agent/related committed purchaser with a $50,000,000 commitment
  • Bank commitments reduced across multiple lenders (Wells Fargo $270M→$170M, PNC $200M→$130M, BofA $100M→$50M, MUFG $300M→$190M, TD $230M→$150M, US Bank $200M→$130M, Truist $200M→$130M)
  • Amended and restated $7.0B credit agreement entered; maturity extended to July 31, 2031
  • Leverage ratio covenant (Section 6.05) reaffirmed in the performance undertaking
  • No financial data (revenue, EPS, etc.) reported in this filing

Financial Impact

Receivables facility reduced by $500M (from $1.5B to $1.0B); accordion increased by $500M (from $500M to $1.0B); new $7.0B credit agreement with 5-year maturity

total debt capacityliquiditydebt maturity profile

Risk Factors

  • No material risks identified; routine capital management
  • Reduced securitization capacity could slightly constrain short-term funding if accordion is not used

Market Snapshot

Exchange
NYSE
Sector
Wholesale-Drugs, Proprietaries & Druggists' Sundries
Analyst Consensus
75% bullish (20 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 2 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001104659-26-090691
Document: tm2621845d1_ex10-1.htm0001104659-26-090691

Track record

12 reports on COR

Performance horizon

1 of 4 bullish or bearish reports moved the stock their way by T+1. Best: +6.03% at T+20 after the Aug 5, 2026 report. 1 of 4 went positive at some point.

Filters
  1. Nov 4, 202612d ago 8-K Neutral 2/10 Entry $354.00 to $339.68 Now $356.94 +0.83% ▼ −4.05% +0.36% vs SPY
  2. Nov 4, 202612d ago 8-K Bullish 6/10 Entry $354.00 to $339.68 Now $356.94 +0.83% ▼ −4.05% +0.36% vs SPY
  3. Oct 21, 202626d ago 8-K Bullish 7/10 Entry $340.43 to $338.48 Now $356.94 +4.85% ▼ −0.57% +0.61% vs SPY
  4. Oct 20, 202627d ago Institutional Cluster Mixed 3/10 Entry $340.43 to $338.48 Now $356.94 +4.85% ▼ −0.57% +0.61% vs SPY
  5. Sep 25, 20267w ago 8-K Neutral 2/10 Entry $306.92 to $303.81 Now $356.94 +16.30% ▼ −1.01% −0.27% vs SPY
  6. Aug 21, 202612w ago Institutional Cluster Mixed 6/10 Entry $318.04 to $323.77 Now $356.94 +12.23% ▲ +1.80% +2.10% vs SPY
  7. Aug 5, 202614w ago 8-K Neutral 3/10 Viewing Entry $317.22 to $325.01 Now $356.94 +12.52% ▲ +2.46% +2.62% vs SPY
  8. Aug 5, 202614w ago 8-K Bullish 6/10 Entry $317.22 to $325.01 Now $356.94 +12.52% ▲ +2.46% +2.62% vs SPY
  9. Jun 15, 202622w ago 8-K Neutral 2/10 Entry $281.46 to $277.09 Now $356.94 +26.82% ▼ −1.55% −0.30% vs SPY
  10. May 29, 202624w ago 8-K Neutral 3/10 Entry $264.69 to $264.84 Now $356.94 +34.85% ▲ +0.06% −0.10% vs SPY
Showing 10 of 12

US Market Status

Market Closed · Opens Wed (14h 10m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 5, 2026